Efficacy and safety of dapagliflozin in children with kidney disease: real-world data.

Naye Choi Ji Hyun Kim Peong Gang Park Hyeonju Lee Jeesu Min Hye Won Park Yo Han Ahn Hee Gyung Kang

Published in: Pediatric nephrology (Berlin, Germany) (2024)

Dapagliflozin has not been associated with serious side effects. Further prospective clinical trials are needed to confirm the efficacy and safety of dapagliflozin in children with kidney disease.

Keyphrases

clinical trial
young adults
big data
machine learning
study protocol